Roche skin cancer drug meets main goal in combination study

July 14, 2014 6:52 AM

9 0

Roche skin cancer drug meets main goal in combination study

ZURICH (Reuters) - An experimental drug from Roche helped people with an advanced form of skin cancer live longer without their disease worsening when used in combination with another treatment, the Swiss drugmaker said on Monday.

Pharmaceutical companies are looking to combination therapy to yield better results and drug cocktails are expected to be crucial as oncologists seek to block cancer on multiple fronts.

Read more

To category page

Loading...